Companies: 10,795·Total market cap: $144.5T
Cannabis Global, Inc.

Cannabis Global, Inc.

CBGLOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$56821
P/E Ratio
52W High$0.0003
52W Low$0.00001

Cannabis Global, Inc. (CBGL) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CBGL · free cash flow · updated Jun 9, 2026

Core FCF metrics

Free cash flow was −$65,089 for FY2024 (fiscal year ending 2024-08-31), up 33.7% year-over-year

FY2024 Free Cash Flow−$65,089▲ +33.7% YoY
Trailing 12M (TTM)−$108,288trailing 4 quarters sum
FCF Margin
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
cbgl free cash flow history · cbgl free cash flow chart · cbgl free cash flow growth rate · cbgl free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2024Latest−$65,089▲ +33.7%
FY2023−$98,220▲ +90.1%-41.1%
FY2022−$988,388▲ +33.2%-90.8%
FY2021−$1.5M▲ +3.7%-92.5%
FY2020−$1.5M▼ 1146.0%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
cbgl free cash flow 2024 · cbgl free cash flow 2023 · cbgl free cash flow 2022 · cbgl operating cash flow

FCF valuation metrics

Cannabis Global, Inc. (CBGL) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)
N/A
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
N/A
TTM FCF ÷ Shares Outstanding
Price / FCF
N/A
Share Price ÷ FCF per Share
EV / FCF (TTM)
N/A
Enterprise Value basis
!

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-08-31
cbgl price to free cash flow · cbgl free cash flow yield · cbgl free cash flow per share · cbgl price to cash flow ratio

Cash flow statement summary

For FY2024, Cannabis Global, Inc. generated −$0.1M in operating cash flow and spent 0M in capital expenditures, yielding −$0.1M in free cash flow.

Operating Activities
−$0.1M
Cash from core business operations
2024-08-31
Investing Activities
+$0.0M
CapEx, acquisitions & investments
2024-08-31
Financing Activities
+$0.1M
Buybacks, dividends & debt
2024-08-31
FCF FormulaOperating CF (−$0.1M) − |CapEx| (0M) = FCF (−$0.1M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
cbgl cash flow statement · cbgl cash flow statement 2024 · cbgl operating cash flow · cbgl cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Cannabis Global, Inc.
Cannabis Global, Inc.YOU
CBGL
−$65,089+33.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Cannabis Global, Inc. (CBGL) reported free cash flow of −$65,089 for FY2024 (fiscal year ending 2024-08-31), up 33.7% year-over-year.

Cannabis Global, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

CBGL free cash flow · 8 questions

Cannabis Global, Inc. free cash flow was −$65,089 for FY2024, up 33.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$108,288.

CBGL free cash flowCBGL FCFCBGL FCF 2024CBGL free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Cannabis Global, Inc. · Cannabis Global, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026